Correction to: Effect of timing of bronchodilator therapy initiation on exacerbations in patients with chronic obstructive pulmonary disease: a retrospective cohort study

Correction to: Effect of timing of bronchodilator therapy initiation on exacerbations in patients with chronic obstructive pulmonary disease: a retrospective cohort study

Bibliographic Details
Main Authors:	Hideyasu Yamada, Isao Matsumoto, Naoyuki Makita, Yoshifumi Arita, Nobuya Hayashi, Kurena Mitsuoka, Naoki Tashiro, Nobuyuki Hizawa
Format:	Article
Language:	English
Published:	BMC 2022-11-01
Series:	Respiratory Research
Online Access:	https://doi.org/10.1186/s12931-022-02219-y

Similar Items

Effect of timing of bronchodilator therapy initiation on exacerbations in patients with chronic obstructive pulmonary disease: a retrospective cohort study
by: Hideyasu Yamada, et al.
Published: (2022-09-01)

Regional differences in the incidence of asthma exacerbations in Japan: A heat map analysis of healthcare insurance claims data
by: Akihito Yokoyama, et al.
Published: (2022-01-01)

Optimizing bronchodilation in the prevention of COPD exacerbations
by: Marc Miravitlles, et al.
Published: (2017-06-01)

Exacerbation rates in Japanese patients with obstructive lung disease: A subanalysis of the prospective, observational NOVELTY study
by: Tomotaka Kawayama, et al.
Published: (2024-01-01)

Prevention of copd exacerbations. Focus on dual bronchodilators
by: V. V. Arkhipov
Published: (2018-10-01)

Short-acting bronchodilators for the management of acute exacerbations of chronic obstructive pulmonary disease in the hospital setting: systematic review
by: Zoe A. Kopsaftis, et al.
Published: (2018-11-01)

Which bronchodilator reversibility criteria can predict severe acute exacerbation in chronic obstructive pulmonary disease patients?
by: Junghyun Kim, et al.
Published: (2017-05-01)

Is dual bronchodilator therapy the new GOLD standard for initiating treatment for chronic obstructive pulmonary disease?
by: Ashutosh Nath Aggarwal
Published: (2023-01-01)

Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis
by: Ian Naya, et al.
Published: (2019-03-01)

Real-world outcomes in patients with chronic obstructive pulmonary disease initiating long-acting mono bronchodilator therapy
by: Lindsay G.S. Bengtson, et al.
Published: (2018-05-01)

Bronchodilator reversibility and eosinophilic biomarkers in chronic obstructive pulmonary disease patients
by: H Ameet, et al.
Published: (2025-03-01)

Bronchodilation improves endurance but not muscular efficiency in chronic obstructive pulmonary disease
by: van der Vaart H, et al.
Published: (2011-04-01)

Airway obstruction and bronchodilator responsiveness in adults with acute cough.
by: Vugt, S, et al.
Published: (2012)

Bronchodilator response in residual volume in irreversible airway obstruction
by: AM Balestra, et al.
Published: (2008-05-01)

Global initiative gold and national recommendations on the management of patients with chronic obstructive pulmonary disease (COPD): the place of double bronchodilation
by: A. A. Vizel, et al.
Published: (2019-12-01)

EFFECT OF BRONCHODILATORS ON HEART RATE VARIABILITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: H. H. Shugushev, et al.
Published: (2015-12-01)

EFFECT OF BRONCHODILATORS ON HEART RATE VARIABILITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: H. H. Shugushev, et al.
Published: (2015-12-01)

New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary disease
by: S N Avdeev, et al.
Published: (2019-03-01)

Changing patterns in long-acting bronchodilator trials in chronic obstructive pulmonary disease
by: James F Donohue, et al.
Published: (2011-01-01)

The future of bronchodilation: looking for new classes of bronchodilators
by: Mario Cazzola, et al.
Published: (2019-12-01)

Spirometric Indices after Bronchodilator Test in Obstructive Lung Disease
by: Amir Houshang Mehrparvar, et al.
Published: (2010-08-01)

Spirometric Indices after Bronchodilator Test in Obstructive Lung Disease
by: Amir Houshang Mehrparvar, et al.
Published: (2010-07-01)

Change in individual chronic obstructive pulmonary disease assessment test item scores after short-term bronchodilator therapy and its impact on exacerbation in treatment-naïve patients with chronic obstructive pulmonary disease
by: Bo-Guen Kim, et al.
Published: (2022-07-01)

Common exacerbation-prone phenotypes across asthma and chronic obstructive pulmonary disease (COPD).
by: Kentaro Hyodo, et al.
Published: (2022-01-01)

Analysis of the availability of bronchodilators and anti-inflammatory drugs for patients with chronic obstructive pulmonary disease
by: E. A. Orlova, et al.
Published: (2024-05-01)

Bronchodilator Response in Airflow Obstruction after Treatment of Pulmonary TuberculosisA Retrospective Analysis
by: Marina Pires Nishi, et al.
Published: (2021-03-01)

Benefit of dual bronchodilator therapy on exacerbations in former and current smokers with chronic obstructive pulmonary disease in real-world clinical practice: a multicenter validation study (TOReTO)
by: Yu-Ting Lai, et al.
Published: (2024-10-01)

Bronchodilator-responsive bronchiolar obstruction in term neonates: a case series
by: Beatrice N. Ezenwa, et al.
Published: (2023-07-01)

Investigating effectiveness of adherence of long-acting bronchodilator in chronic obstructive pulmonary disease with influenza infection
by: Kuang-Ming Liao, et al.
Published: (2024-08-01)

Association of Absolute Eosinophil Count and Post-Bronchodilator Reversibility in the Chronic Obstructive Pulmonary Disease Patients
by: Muhammad Naveed, et al.
Published: (2023-04-01)

The effects of long-acting bronchodilators on total mortality in patients with stable chronic obstructive pulmonary disease
by: Kliber Agnes, et al.
Published: (2010-05-01)

Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease
by: Ramadan WH, et al.
Published: (2015-10-01)

Role of the Bronchodilator Test Defined by the Forced Vital Capacity in Chronic Obstructive Pulmonary Disease Phenotyping
by: Zhang X, et al.
Published: (2020-05-01)

Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease
by: Pisi R, et al.
Published: (2015-06-01)

An asthmatic case of psoriasiform eruption caused by administration of dupilumab
by: Takashi Matsuda, et al.
Published: (2020-07-01)

Oral Corticosteroid Reduction Between Biologics Initiated and Non-Initiated Patients with Severe Asthma
by: Tanaka A, et al.
Published: (2023-08-01)

Assessment of Airway Bronchodilation by Spirometry Compared to Airway Obstruction in Young Children with Asthma
by: Daphna Vilozni, et al.
Published: (2016-01-01)

Decrease in the use of bronchodilators in the management of bronchiolitis after applying improvement initiatives
by: David Andina Martínez, et al.
Published: (2022-06-01)

Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial studying bronchodilators in preventing exacerbations of bronchiectasis
by: John R Hurst, et al.
Published: (2023-08-01)

PHARMACOECONOMIC STUDY OVER USE OF ANTICHOLINERGIC BRONCHODILATORS (SPIRIVA AND ATROVENT) FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: A. U. Kulikov, et al.
Published: (2015-03-01)